Agios Pharma (AGIO) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts AGIO Hot Sheet
Join SI Premium – FREE
Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.74), $0.07 better than the analyst estimate of ($1.81). Revenue for the quarter came in at $800 thousand versus the consensus estimate of $2.75 million.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tredegar Corp. (TG) Tops Q2 EPS by 18c
- MetaVia Inc. (MTVA) Tops Q2 EPS by 73c
- Evommune, Inc. (EVMN) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
